Federal Competition Commission: Mexico's antitrust regulator blocks Nestle's proposed acquisition of Pfizer's infant nutrition business
MLex Summary: Mexico's Federal Competition Commission (CFC) announced Tuesday that it has rejected Nestle's proposed $11.9 billion acquisition of Pfizer's infant nutrition business as it would give the companies a high concentration...To view the full article, register now.
Already a subscriber? Click here to view full article